Search products

Search by product name, CAT, CAS, molecular formula or chemical name.

Trusted Partner for Reference Standards and Beyond
Products About us Facility Quality system OUR DIVISIONS SimSon Chemtech Speciality & fine chemicals SimSon Chemie Research chemicals supply SimSon Lifescience Services CRO, CDMO & analytical testing Contact us Careers
Home/ Products/ Tofacitinib/ Tofacitinib Intermediate

Tofacitinib Intermediate

Structure of Tofacitinib Intermediate
CAT. No. T990093
CAS No. 1228879-37-5
Mol. Formula C14H22N2.2HCl
Mol. Weight 291.26 g/mol
Chemical Name 1-Benzyl-4-methyl-3-(methylamino)piperidine dihydrochloride
Synonyms 3-Piperidinamine, N,4-dimethyl-1-(phenylmethyl)-, hydrochloride (1:2)
Smiles Code
Stock Status Instock

Technical Description

Tofacitinib Intermediate is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.

Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.

Product Applications & Regulatory Search Terms:

Buy 1228879-37-5 Purchase 1228879-37-5 Order 1228879-37-5 Enquire 1228879-37-5 1228879-37-5 price 1228879-37-5 supplier 1228879-37-5 manufacturer 1228879-37-5 exporter Tofacitinib Intermediate for method validation Tofacitinib Intermediate reference standard Tofacitinib Intermediate for ANDA filing Tofacitinib Intermediate for forced degradation studies Tofacitinib Intermediate identification standard Tofacitinib Intermediate for DMF filing Tofacitinib Intermediate HPLC standard Tofacitinib Intermediate supplier Tofacitinib Intermediate manufacturer Tofacitinib Intermediate distributor

Search COA by Batch No.

Find the Certificate of Analysis for a specific product batch.

Request a quote

Tell us what you need. Our technical desk normally replies within one working day.

Request a quote for Tofacitinib Intermediate

Share the required quantity, destination, intended analytical use and supporting documents you need. The technical desk will confirm the applicable product details, availability and quotation.

FOR INTERNATIONAL +91 87673 60663 info@simsonpharma.com
Technical desk · Mon–Sat, 09:30–18:30 IST
Tofacitinib Intermediate · T990093
PRODUCT NAME
This form is protected by server-side validation, rate limiting and spam detection. By sending it, you agree to our privacy policy.
We reply within one working day.
DISCLAIMER This page supports product identification and initial technical evaluation. Specifications, assigned values, pack options, availability and documentation may vary by product or batch; verify the applicable details in the current quotation, label and supplied records before use. The purchaser or importer is responsible for determining method suitability and meeting local regulatory, transport and import requirements. For research, analytical and quality-control use only. Not for human or veterinary consumption, and not for use as a medicine.
Tofacitinib Intermediate CAT. No. T990093 · CAS 1228879-37-5 · 291.26 g/mol
✕
Structure of Tofacitinib Intermediate

Sample structure

Catalogue no.: — CAS no.: — Formula: — Mol. weight: —

Illustrative sample structure
SimSon — Science Standards Solutions
D-U-N-S Registered — Dun & Bradstreet D-U-N-S® REGISTERED Verified by Dun & Bradstreet
OFFICES & LABORATORIES
REGISTERED OFFICE · MUMBAI B-307, Sarita Building, Prabhat Industrial Estate, Near Dahisar Toll Naka, Dahisar (East), Mumbai- 400068, Maharashtra, India
CORPORATE OFFICE · MUMBAI Unit 1001-1006, The Platina, Tanvi Complex, S. V. Road, Dahisar East, Mumbai 400068, India
LABORATORY · HYDERABAD Shed 6A, TYPE III, TSIIC, Prashanthi Nagar, Kukatpally, Hyderabad 500072, India
REGIONAL OFFICE · AHMEDABAD Survey Number 375 Paiki 1, Plot Number 11, Shivam 5, Near Sumip Composite, Panchratna Estate, Village Changodar, Taluka Sanand, District Ahmedabad, Gujarat-382213
TALK TO THE RIGHT DESK
© 2026 SimSon Pharma Limited · All rights reserved